Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJH3E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,848
Award facts
- Contract value 100% obligated
- $21,847.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,847.67 to AmerisourceBergen Drug Corp for the supply of KESIMPTA 20 MG/0.4 ML pen injectors, with an ultimate completion date of January 13, 2026. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated consistent capability in fulfilling federal medical procurement needs through its competitive awards from the DLA Medical Supply Chain. The company's federal contract portfolio encompasses a broad spectrum of pharmaceutical products across multiple therapeutic domains, from specialty medications to vaccines and medical devices, supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This particular delivery order for KESIMPTA, an immunosuppressant medication, reflects the company's ongoing role in supplying critical pharmaceutical commodities to support federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJH3E?
SPE2DR26FJH3E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FJH3E worth?
The government has obligated $21,848 on SPE2DR26FJH3E.
Is contract SPE2DR26FJH3E an order under another contract?
Yes. SPE2DR26FJH3E is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH3E competed?
The extent of competition for SPE2DR26FJH3E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award